3 Companies That May Be Trading Below Their Estimated Value

As the U.S. stock market experiences a period of optimism, with major indices like the S&P 500 and Nasdaq reaching their highest levels since February, investors are encouraged by positive inflation data and progress in China-U.S. trade talks. In such an environment, identifying companies that may be trading below their estimated value can present opportunities for investors looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Click here to see the full list of 174 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Ligand Pharmaceuticals (LGND)

Overview: Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that develops and licenses biopharmaceutical assets globally, with a market cap of $2.11 billion.

Operations: The company's revenue primarily comes from the development and licensing of biopharmaceutical assets, amounting to $181.49 million.

Estimated Discount To Fair Value: 49.7%

Ligand Pharmaceuticals, trading at US$113.42, is significantly undervalued based on discounted cash flow analysis with a fair value estimate of US$225.7. Despite a recent net loss of US$42.45 million in Q1 2025, revenue increased to US$45.33 million from the previous year. The company expects total revenue between US$180 million and US$200 million for 2025 and anticipates becoming profitable within three years, with earnings projected to grow over 64% annually.

• According our earnings growth report, there's an indication that Ligand Pharmaceuticals might be ready to expand.
• Take a closer look at Ligand Pharmaceuticals' balance sheet health here in our report.

LPL Financial Holdings (LPLA)

Overview: LPL Financial Holdings Inc. offers a comprehensive platform of brokerage and investment advisory services to independent financial advisors and institutional advisors across the United States, with a market cap of approximately $30.33 billion.

Operations: The company's revenue primarily comes from its brokerage segment, which generated $12.92 billion.

Estimated Discount To Fair Value: 28.9%

LPL Financial Holdings, with a trading price of US$379.22, is significantly undervalued based on discounted cash flow analysis, with a fair value estimate of US$533.73. Despite revenue growth forecasts at 10.9% annually, slower than the desired 20%, its earnings are expected to grow faster than the market at 16.1% per year. Recent initiatives like the Alts Learning Hub and WealthVision Essentials enhance advisor capabilities and may support future cash flow improvements despite current debt coverage concerns by operating cash flow.

• Insights from our recent growth report point to a promising forecast for LPL Financial Holdings' business outlook.
• Get an in-depth perspective on LPL Financial Holdings' balance sheet by reading our health report here.

Levi Strauss (LEVI)

Overview: Levi Strauss & Co. is a global apparel company that designs, markets, and sells clothing and accessories for men, women, and children with a market capitalization of approximately $6.93 billion.

Operations: Levi Strauss & Co.'s revenue is generated from its operations in Asia ($1.10 billion), Europe ($1.59 billion), and the Americas ($3.25 billion).

Estimated Discount To Fair Value: 31.6%

Levi Strauss, trading at US$17.55, is highly undervalued based on discounted cash flow analysis with a fair value of US$25.66. The company has demonstrated strong earnings growth of 185.3% over the past year and forecasts suggest continued profit expansion at 20.9% annually, outpacing the broader U.S. market's expected growth rate of 14.4%. Despite slower revenue growth projections at 1.1% per year, Levi's robust return on equity forecasted to reach 23% supports its valuation appeal amidst recent executive transitions and shareholder engagements.

• In light of our recent growth report, it seems possible that Levi Strauss' financial performance will exceed current levels.
• Navigate through the intricacies of Levi Strauss with our comprehensive financial health report here.

Key Takeaways

• Get an in-depth perspective on all 174 Undervalued US Stocks Based On Cash Flows by using our screener here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com